Dudediligence.

Palvella Therapeutics, Inc

PVLANASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

14.4M

on 2026-06-30, from 1.24M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

5M10M15MMar2024JunSepDecMar2025JunSepDecMar2026$125.00Jun

Newest

$300.0M

S-3 of 2026-01-02. 1 prospectus supplement filed under it since. S-3 ↗

3 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-04 is not read yet.

Cash

27.5 quarters

$250.6M on 2026-06-30 ÷ $9.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-02-26Public offering1,600,000$125.00$200.0M424B5 ↗
2024-12-16Private placement incl. 2.47M pre-funded5,634,504not read$78.9M8-K ↗